Opening book details…
About this Medicine article
Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab by G. Guhl; B. Díaz-Ley; J. Fernández-Herrera is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- G. Guhl; B. Díaz-Ley; J. Fernández-Herrera
- Publisher
- Elsevier Science; Elsevier ; Ediciones Doyma S.A.; Elsevier BV (ISSN 0001-7310)
- Published
- 2008
- Language
- EN
- Field
- Medicine (Health Sciences)
More by G. Guhl; B. Díaz-Ley; J. Fernández-Herrera
Browse all works by G. Guhl; B. Díaz-Ley; J. Fernández-Herrera